Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Dashboard
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Analytics
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
Membership Levels
By The Numbers
Press Releases
1816 Articles Available
1
76
Can't find what you're looking for? Try our
advanced search
.
FDA Approval
FDA Approves New Cochlear Implant with Easier Access to MRI and Expanded Connectivity Ready for Google's Direct Streaming to Android Smartphones
PR-M06-19-NI-030
Breakthrough Device Designation
FDA Grants Breakthrough Device Designation to Bio-Techne's ExoDx™ Prostate IntelliScore™ (EPI) Test
PR-M06-19-NI-029
M&A
Pfizer to Acquire Array BioPharma
PR-M06-19-NI-027
Clinical Data
Enanta Pharmaceuticals Announces Positive Topline Results in Healthy Adults Infected with Respiratory Syncytial Virus (RSV)
PR-M06-19-NI-028
Leadership
Flatiron Health Appoints Cancer Researcher and Pharmaceutical Executive Dr. Michael Vasconcelles as Chief Medical Officer
PR-M06-19-NI-026
Clinical Trials
GBT Announces Efficacy Data from All Patients Enrolled in Phase 3 Study Sustained Improvements in Hemoglobin with Voxelotor
PR-M06-19-NI-025
Leadership
Novartis Announces New Leader of Pharmaceuticals Business Unit
PR-M06-19-NI-024
Positive Results
Lilly Presents Positive Results for Taltz® vs. Humira®in Patients with Active Psoriatic Arthritis
PR-M06-19-NI-023
Series B Financing
Purigen Biosystems Raises $26.4 Million Series B Financing to Accelerate Commercialization of Automated Sample Preparation Platform
PR-M06-19-NI-022
Track and Trace
IBM, KPMG, Merck and Walmart to Collaborate as Part of FDA’s Program to Evaluate the Use of Blockchain to Protect Pharmaceutical Product Integrity
PR-M06-19-NI-021
Capacity Expansion
Seqens to Unveil New Innovation and Development Center of Excellence
PR-M06-19-NI-019
Drug Development
Novartis Cosentyx® First to Show Efficacy in All Key Manifestations of Psoriatic Arthritis
PR-M06-19-NI-020
Genomic Research
GSK Joins Forces with the University of California to Advance Genomic Research and Improve Drug Discovery
PR-M06-19-NI-018
Announcement
AbCellera Announces Therapeutic Antibody Discovery Collaboration with Gilead in Infectious Disease
PR-M06-19-NI-017
Series A Funding
BlackThorn Therapeutics Closes $76 Million Series B to Advance Targeted Therapeutics for Mental Health
PR-M06-19-NI-016
Collaboration
Polar Speed and Marken Join Forces in the UK
PR-M06-19-NI-015
M&A
Aptar Acquires Nanopharm and Gateway Analytical, Broadening Pharma Services Platform to Accelerate Customer Drug Development
PR-M06-19-NI-014
Strategic Partnership
nference Enters into an R&D Data Science Strategic Partnership with Janssen
PR-M06-19-NI-013
FDA Approval
FDA Permits Marketing of First Medical Device for IBS Pain Relief in Adolescent Patients
PR-M06-19-NI-012
Innovation
Medtronic Announces Its Forthcoming Robotic Assisted Surgical Platform to Feature Three-Dimensional Vision System from KARL STORZ
PR-M06-19-NI-011
Launch
TrialAssure Launches TrialResults.com for Clinical Trial Sponsors to Publicly Post Plain Language Summaries
PR-M06-19-NI-010
Finance
SAGA Raises 40 Million SEK (€3.7 Million) to Advance Ultrasensitive Cancer Liquid Biopsies
PR-M06-19-NI-009
Agreement
Genmab Signs Agreement with Janssen for Next-Generation CD38 Antibody, HexaBody®-CD38
PR-M06-19-NI-007
Leadership
Changes in Roche's Board of Directors and Corporate Executive Committee
PR-M06-19-NI-008
1
76
»
